StockData
Integrated BioPharma Inc logo

Integrated BioPharma Inc (INBP) stock

INBPOTCPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$0.18+0.00 (0.00%)

Close on Oct 19, 2026Market cap $5.59MP/E –Yield –

Integrated BioPharma operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Integrated BioPharma's operating cash flow for the twelve months ending Jun 30, 2026 was $1.24M, down 39.9% year over year. For fiscal 2026 it was $1.24M, down 39.9% from the year before. The highest annual figure on record is $4.09M in fiscal 2022.

Annual operating cash flow

PeriodPeriod endValueChange
FY2026Jun 30, 2026$1.24M-39.9%
FY2025Jun 30, 2025$2.07M+119.0%
FY2024Jun 30, 2024$943.00K-23.5%
FY2023Jun 30, 2023$1.23M-69.9%
FY2022Jun 30, 2022$4.09M+34.1%
FY2021Jun 30, 2021$3.05M+127.8%
FY2020Jun 30, 2020$1.34M+308.2%
FY2019Jun 30, 2019$328.00K-71.9%
FY2018Jun 30, 2018$1.17M+194.2%
FY2017Jun 30, 2017$397.00K–
FY2016Jun 30, 2016-$594.00K–
FY2015Jun 30, 2015-$113.00K-106.0%
FY2014Jun 30, 2014$1.88M–
FY2013Jun 30, 2013-$1.44M–
FY2012Jun 30, 2012-$771.00K-296.7%
FY2011Jun 30, 2011$392.00K–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026-$1.19M-302.0%
Q3 FY2026CQ1 2026Mar 31, 2026$517.00K-16.1%
Q2 FY2026CQ4 2025Dec 31, 2025$617.00K+207.0%
Q1 FY2026CQ3 2025Sep 30, 2025$1.30M+98.0%
Q4 FY2025CQ2 2025Jun 30, 2025$591.00K–
Q3 FY2025CQ1 2025Mar 31, 2025$616.00K-62.5%
Q2 FY2025CQ4 2024Dec 31, 2024$201.00K–
Q1 FY2025CQ3 2024Sep 30, 2024$657.00K-50.0%
Q4 FY2024CQ2 2024Jun 30, 2024-$186.00K–
Q3 FY2024CQ1 2024Mar 31, 2024$1.64M+11.8%
Q2 FY2024CQ4 2023Dec 31, 2023-$1.83M–
Q1 FY2024CQ3 2023Sep 30, 2023$1.31M+32.4%
Q4 FY2023CQ2 2023Jun 30, 2023-$1.19M-143.9%
Q3 FY2023CQ1 2023Mar 31, 2023$1.47M+117.8%
Q2 FY2023CQ4 2022Dec 31, 2022-$44.00K–
Q1 FY2023CQ3 2022Sep 30, 2022$992.00K-52.8%
Q4 FY2022CQ2 2022Jun 30, 2022$2.70M+279.6%
Q3 FY2022CQ1 2022Mar 31, 2022$675.00K-42.5%
Q2 FY2022CQ4 2021Dec 31, 2021-$1.39M–
Q1 FY2022CQ3 2021Sep 30, 2021$2.10M+9.5%
Q4 FY2021CQ2 2021Jun 30, 2021$712.00K–
Q3 FY2021CQ1 2021Mar 31, 2021$1.17M-52.9%
Q2 FY2021CQ4 2020Dec 31, 2020-$754.00K–
Q1 FY2021CQ3 2020Sep 30, 2020$1.92M+13.8%
Q4 FY2020CQ2 2020Jun 30, 2020-$2.21M-452.5%
Q3 FY2020CQ1 2020Mar 31, 2020$2.49M+305.0%
Q2 FY2020CQ4 2019Dec 31, 2019-$627.00K–
Q1 FY2020CQ3 2019Sep 30, 2019$1.69M+184.1%
Q4 FY2019CQ2 2019Jun 30, 2019$627.00K–
Q3 FY2019CQ1 2019Mar 31, 2019$615.00K-12.5%
Q2 FY2019CQ4 2018Dec 31, 2018-$1.51M–
Q1 FY2019CQ3 2018Sep 30, 2018$593.00K-63.0%
Q4 FY2018CQ2 2018Jun 30, 2018-$175.00K–
Q3 FY2018CQ1 2018Mar 31, 2018$703.00K+5.2%
Q2 FY2018CQ4 2017Dec 31, 2017-$964.00K-189.8%
Q1 FY2018CQ3 2017Sep 30, 2017$1.60M–
Q4 FY2017CQ2 2017Jun 30, 2017-$818.00K–
Q3 FY2017CQ1 2017Mar 31, 2017$668.00K–
Q2 FY2017CQ4 2016Dec 31, 2016$1.07M–
Q1 FY2017CQ3 2016Sep 30, 2016-$526.00K–

More Integrated BioPharma figures

See a number that looks wrong?